1. Home
  2. BLCO vs NVTS Comparison

BLCO vs NVTS Comparison

Compare BLCO & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.80

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Logo Navitas Semiconductor Corporation

NVTS

Navitas Semiconductor Corporation

HOLD

Current Price

$31.81

Market Cap

5.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLCO
NVTS
Founded
1853
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.7B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
BLCO
NVTS
Price
$15.80
$31.81
Analyst Decision
Buy
Buy
Analyst Count
11
5
Target Price
$18.45
$6.68
AVG Volume (30 Days)
469.3K
32.0M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,101,000,000.00
$45,916,000.00
Revenue This Year
$8.65
N/A
Revenue Next Year
$5.59
$71.28
P/E Ratio
N/A
N/A
Revenue Growth
6.47
N/A
52 Week Low
$11.22
$4.95
52 Week High
$18.92
$29.50

Technical Indicators

Market Signals
Indicator
BLCO
NVTS
Relative Strength Index (RSI) 42.13 75.27
Support Level $15.67 $7.35
Resistance Level $16.41 N/A
Average True Range (ATR) 0.38 3.01
MACD -0.00 0.91
Stochastic Oscillator 18.00 89.35

Price Performance

Historical Comparison
BLCO
NVTS

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components. Geographically, the company operates in Hong Kong, China, Europe, the United States, Rest of Asia, and Others. The majority of revenue is generated from Hong Kong.

Share on Social Networks: